Discussion on immunotherapy and Head and Neck Cancer.
Dates and Times
Start: 4/7/2021 12:00 PM
End: 4/7/2021 1:00 PM
1. Identify patients who are appropriate for immunotherapy in HNC,
2. Identify safety concerns and management when using immunotherapy in HNC,
3. Novel strategies to overcome resistance to immunotherapy in HNC
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.